Table 5.
ASCQ-Me domaina | Less severe VOCs | More severe VOCs | Pb | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
N | Mean | SD | Median | IQR | N | Mean | SD | Median | IQR | ||
Emotional impact | 188 | 48.00 | 7.36 | 47.40 | 43.10–51.50 | 115 | 44.24 | 8.48 | 43.70 | 39.90–48.70 | < 0.001 |
Social functioning impact | 188 | 49.22 | 8.61 | 48.80 | 43.90–54.00 | 115 | 43.37 | 9.05 | 42.10 | 36.80–47.20 | < 0.001 |
Stiffness impact | 188 | 47.49 | 7.80 | 46.70 | 44.00–51.00 | 115 | 44.97 | 8.99 | 45.40 | 38.40–49.50 | 0.008 |
Sleep impact | 188 | 49.52 | 6.58 | 49.70 | 45.00–53.90 | 115 | 47.40 | 6.29 | 46.70 | 43.20–51.10 | 0.005 |
Pain impact | 188 | 49.16 | 8.93 | 47.10 | 44.40–55.80 | 115 | 45.75 | 10.00 | 44.40 | 38.30–51.20 | 0.002 |
More severe VOCs: ASCQ-Me Pain Episode Severity score ≥ 55 (½ SD worse than the benchmark score); less severe VOCs: ASCQ-Me Pain Episode Severity score < 55
ASCQ-Me Adult Sickle Cell Quality of Life Measurement Information System, VOCs vaso-occlusive crises, SD standard deviation, IQR inter-quartile range, HRQoL Health-related quality of life
aHigher ASCQ-Me impact scores indicate better functioning
bAfter Bonferroni correction, all associations remained statistically significant, with P < the Bonferroni correction-adjusted critical value of 0.01